Awards and patents

CELLINK is honored to receive praise and recognition for its innovative work. Additionally, the company regularly seeks out patents in different regions in order to distinguish and protect its unique technology. Below is a summary of the awards and patents the company received during the past fiscal year.

CELLINK and Prellis Biologics awarded Merck Innovation Award for empowering pharmaceutical research.

CELLINK began collaborating with Prellis Biologics to develop the Holograph X bioprinter in 2018, and the technology was recognized for enabling innovative capabilities for the pharmaceutical industry. The Holograph X, a bioprinter that leverages high-resolution holographic stereolithography to bioprint small structures, earned CELLINK a top honor as an innovative medical device with the potential to change what’s possible in pharmaceutical medicine.